Helene Eckhardt

469 total citations
16 papers, 183 citations indexed

About

Helene Eckhardt is a scholar working on Economics and Econometrics, General Health Professions and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Helene Eckhardt has authored 16 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 5 papers in General Health Professions and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Helene Eckhardt's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Cardiac, Anesthesia and Surgical Outcomes (4 papers) and Pharmaceutical Economics and Policy (4 papers). Helene Eckhardt is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Cardiac, Anesthesia and Surgical Outcomes (4 papers) and Pharmaceutical Economics and Policy (4 papers). Helene Eckhardt collaborates with scholars based in Germany, Belgium and Poland. Helene Eckhardt's co-authors include Reinhard Busse, Димитра Пантели, Tanja Rombey, Michael Kulig, Wilm Quentin, Juliane Winkelmann, Ulrike Nimptsch, Elke Berger, Cornelia Henschke and Hendrikje Lantzsch and has published in prestigious journals such as BMC Medicine, Frontiers in Pharmacology and BMJ Open.

In The Last Decade

Helene Eckhardt

14 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helene Eckhardt Germany 7 80 46 25 20 19 16 183
Anna A. Bonenkamp Netherlands 7 46 0.6× 44 1.0× 13 0.5× 14 0.7× 18 0.9× 15 188
Qi Cao Netherlands 11 96 1.2× 31 0.7× 24 1.0× 54 2.7× 12 0.6× 26 345
Elle Pope United States 7 97 1.2× 43 0.9× 13 0.5× 11 0.6× 25 1.3× 15 257
Kelly Compton United States 7 42 0.5× 56 1.2× 43 1.7× 12 0.6× 22 1.2× 11 212
Pavithra Vijayakumar United States 8 47 0.6× 39 0.8× 12 0.5× 17 0.8× 29 1.5× 17 350
Hussain S. Lalani United States 7 76 0.9× 48 1.0× 6 0.2× 23 1.1× 14 0.7× 22 194
Nataša Mihailović Serbia 5 42 0.5× 64 1.4× 14 0.6× 9 0.5× 14 0.7× 24 166
E. Karampli Greece 11 90 1.1× 75 1.6× 12 0.5× 26 1.3× 13 0.7× 36 271
Brian MacKenna United Kingdom 9 35 0.4× 61 1.3× 32 1.3× 14 0.7× 15 0.8× 42 203
John Wiesman United States 6 67 0.8× 57 1.2× 15 0.6× 18 0.9× 23 1.2× 14 199

Countries citing papers authored by Helene Eckhardt

Since Specialization
Citations

This map shows the geographic impact of Helene Eckhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helene Eckhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helene Eckhardt more than expected).

Fields of papers citing papers by Helene Eckhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helene Eckhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helene Eckhardt. The network helps show where Helene Eckhardt may publish in the future.

Co-authorship network of co-authors of Helene Eckhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Helene Eckhardt. A scholar is included among the top collaborators of Helene Eckhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helene Eckhardt. Helene Eckhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
3.
Eckhardt, Helene, Sabine Fuchs, Tanja Rombey, et al.. (2023). Utilization of innovative medical technologies in German inpatient care: does evidence matter?. Health Research Policy and Systems. 21(1). 100–100.
4.
5.
Eckhardt, Helene, et al.. (2023). Challenges and Solutions for the Benefit Assessment of Tumor-Agnostic Therapies in Germany. Value in Health. 26(6). 854–864. 4 indexed citations
6.
Eckhardt, Helene, et al.. (2023). International strategies, experiences, and payment models to incentivise day surgery. Health Policy. 140. 104968–104968. 7 indexed citations
7.
Rombey, Tanja, et al.. (2023). Cost-effectiveness of prehabilitation prior to elective surgery: a systematic review of economic evaluations. BMC Medicine. 21(1). 265–265. 29 indexed citations
8.
Lantzsch, Hendrikje, et al.. (2022). Digital health applications and the fast-track pathway to public health coverage in Germany: challenges and opportunities based on first results. BMC Health Services Research. 22(1). 1182–1182. 23 indexed citations
9.
Пантели, Димитра, Tanja Rombey, Elke Berger, et al.. (2022). Health care patterns and policies in 18 European countries during the first wave of the COVID-19 pandemic: an observational study. European Journal of Public Health. 32(4). 557–564. 2 indexed citations
10.
Eckhardt, Helene, Hendrikje Lantzsch, Tanja Rombey, et al.. (2021). Implementation of innovative medical technologies in German inpatient care: patterns of utilization and evidence development. Implementation Science. 16(1). 94–94. 4 indexed citations
11.
Berger, Elke, Juliane Winkelmann, Helene Eckhardt, et al.. (2021). A country-level analysis comparing hospital capacity and utilisation during the first COVID-19 wave across Europe. Health Policy. 126(5). 373–381. 42 indexed citations
12.
Rombey, Tanja, Helene Eckhardt, & Wilm Quentin. (2020). Cost-effectiveness of prehabilitation prior to elective surgery compared to usual preoperative care: protocol for a systematic review of economic evaluations. BMJ Open. 10(12). e040262–e040262. 5 indexed citations
13.
Fuchs, Sabine A., et al.. (2019). PET/PET-CT Evidenz zum Bedarf und zur Planung in Deutschland und Österreich: Update 2018. DepositOnce. 2 indexed citations
14.
Stawowczyk, Ewa, Krzysztof Piotr Malinowski, Paweł Kawalec, et al.. (2019). Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries. Frontiers in Pharmacology. 10. 17 indexed citations
15.
Пантели, Димитра, et al.. (2016). Published and unpublished evidence in coverage decision-making for pharmaceuticals in Europe: existing approaches and way forward. Health Research Policy and Systems. 14(1). 6–6. 9 indexed citations
16.
Пантели, Димитра, et al.. (2015). From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries. Health Research Policy and Systems. 13(1). 39–39. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna A. Bonenkamp Breakdown of academic impact, for papers by Qi Cao Breakdown of academic impact, for papers by Elle Pope Breakdown of academic impact, for papers by Kelly Compton Breakdown of academic impact, for papers by Pavithra Vijayakumar Breakdown of academic impact, for papers by Hussain S. Lalani Breakdown of academic impact, for papers by Nataša Mihailović Breakdown of academic impact, for papers by E. Karampli Breakdown of academic impact, for papers by Brian MacKenna Breakdown of academic impact, for papers by John Wiesman
Rankless by CCL
2026